BACKGROUND: Infants born to HIV-1 infected mothers may have increased risk for tuberculosis (TB), but the prevalence of TB infection in this population is undefined. In contrast to tuberculin skin tests that are confounded by recent bacille Calmette-Guérin (BCG) vaccination, TB interferon gamma release assays (IGRAs) do not cross-react with BCG and enable detection of TB infection in infancy. METHODS: In a nested observational cohort of HIV-1 infected Kenyan mothers and their infants, we conducted T-SPOT.TB assays on cryopreserved peripheral blood mononuclear cells from 6-month-old infants without prior active TB. Maternal and infant correlates of infant TB infection were assessed. RESULTS: One hundred and eight-two infants were tested with T-SPOT.TB. Of 128 infants with determinate T-SPOT.TB results, the prevalence of a positive T-SPOT.TB was 10.9% [95% confidence interval (CI): 6.1-17.7%]. All infants were BCG-vaccinated and 7.0% were HIV-1 infected. Positive infant T-SPOT.TB was associated with maternal active TB (odds ratio: 15.5, 95% CI: 1.3-184; P = 0.04) and prolonged infant fever (>1 month) (odds ratio: 18.8, 95% CI: 1.6-223; P = 0.03). CONCLUSIONS: We observed a high prevalence of TB infection in 6-month-old HIV-1 exposed infants. Improved TB detection and prevention are warranted in HIV-1 exposed infants at high risk for active TB disease.
BACKGROUND:Infants born to HIV-1 infected mothers may have increased risk for tuberculosis (TB), but the prevalence of TB infection in this population is undefined. In contrast to tuberculin skin tests that are confounded by recent bacille Calmette-Guérin (BCG) vaccination, TB interferon gamma release assays (IGRAs) do not cross-react with BCG and enable detection of TB infection in infancy. METHODS: In a nested observational cohort of HIV-1 infected Kenyan mothers and their infants, we conducted T-SPOT.TB assays on cryopreserved peripheral blood mononuclear cells from 6-month-old infants without prior active TB. Maternal and infant correlates of infantTB infection were assessed. RESULTS: One hundred and eight-two infants were tested with T-SPOT.TB. Of 128 infants with determinate T-SPOT.TB results, the prevalence of a positive T-SPOT.TB was 10.9% [95% confidence interval (CI): 6.1-17.7%]. All infants were BCG-vaccinated and 7.0% were HIV-1 infected. Positive infant T-SPOT.TB was associated with maternal active TB (odds ratio: 15.5, 95% CI: 1.3-184; P = 0.04) and prolonged infantfever (>1 month) (odds ratio: 18.8, 95% CI: 1.6-223; P = 0.03). CONCLUSIONS: We observed a high prevalence of TB infection in 6-month-old HIV-1 exposed infants. Improved TB detection and prevention are warranted in HIV-1 exposed infants at high risk for active TB disease.
Authors: Shabir A Madhi; Sharon Nachman; Avy Violari; Soyeon Kim; Mark F Cotton; Raziya Bobat; Patrick Jean-Philippe; George McSherry; Charles Mitchell Journal: N Engl J Med Date: 2011-07-07 Impact factor: 91.245
Authors: Heather J Zar; Mark F Cotton; Stanzi Strauss; Janine Karpakis; Gregory Hussey; H Simon Schaaf; Helena Rabie; Carl J Lombard Journal: BMJ Date: 2006-11-03
Authors: A M Mandalakas; H L Kirchner; C Lombard; G Walzl; H M S Grewal; R P Gie; A C Hesseling Journal: Int J Tuberc Lung Dis Date: 2012-06-11 Impact factor: 2.373
Authors: Sarah Burl; Uche J Adetifa; Momodou Cox; Ebrima Touray; Hilton Whittle; Helen McShane; Sarah L Rowland-Jones; Katie L Flanagan Journal: PLoS One Date: 2010-08-19 Impact factor: 3.240
Authors: D D Panteleeff; G John; R Nduati; D Mbori-Ngacha; B Richardson; J Kreiss; J Overbaugh Journal: J Clin Microbiol Date: 1999-02 Impact factor: 5.948
Authors: B J Marais; R P Gie; H S Schaaf; A C Hesseling; C C Obihara; J J Starke; D A Enarson; P R Donald; N Beyers Journal: Int J Tuberc Lung Dis Date: 2004-04 Impact factor: 2.373
Authors: Annelies Van Rie; Shabir A Madhi; Jayvant R Heera; Stephen Meddows-Taylor; Aaron M Wendelboe; Fiona Anthony; Avy Violari; Caroline T Tiemessen Journal: Clin Vaccine Immunol Date: 2006-02
Authors: David J C Miles; Louis Gadama; Anita Gumbi; Flora Nyalo; Bonus Makanani; Robert S Heyderman Journal: Immunology Date: 2009-12-02 Impact factor: 7.397
Authors: Sylvia M LaCourse; Barbra A Richardson; John Kinuthia; A J Warr; Elizabeth Maleche-Obimbo; Daniel Matemo; Lisa M Cranmer; Jerphason Mecha; Jaclyn N Escudero; Thomas R Hawn; Grace John-Stewart Journal: Clin Infect Dis Date: 2021-07-15 Impact factor: 9.079
Authors: Lisa M Cranmer; Heather R Draper; Anna M Mandalakas; Soyeon Kim; George McSherry; Emma Krezinski; Joan Coetzee; Charles Mitchell; Sharon Nachman; Mercia van der Linde; Mark F Cotton; Anneke C Hesseling Journal: Pediatr Infect Dis J Date: 2018-10 Impact factor: 2.129
Authors: L M Cranmer; A Langat; K Ronen; C J McGrath; S LaCourse; J Pintye; B Odeny; B Singa; A Katana; L Nganga; J Kinuthia; G John-Stewart Journal: Int J Tuberc Lung Dis Date: 2017-03-01 Impact factor: 2.373
Authors: Carina Marquez; Gabriel Chamie; Jane Achan; Anne F Luetkemeyer; Mary Kyohere; Jaffer Okiring; Grant Dorsey; Moses R Kamya; Edwin D Charlebois; Diane V Havlir Journal: Pediatr Infect Dis J Date: 2016-05 Impact factor: 2.129
Authors: Leonardo Martinez; Nathan C Lo; Olivia Cords; Philip C Hill; Palwasha Khan; Mark Hatherill; Anna Mandalakas; Alexander Kay; Julio Croda; C Robert Horsburgh; Heather J Zar; Jason R Andrews Journal: Lancet Respir Med Date: 2019-05-08 Impact factor: 30.700
Authors: Noëmi R Meier; Thomas Volken; Marc Geiger; Ulrich Heininger; Marc Tebruegge; Nicole Ritz Journal: Front Pediatr Date: 2019-05-29 Impact factor: 3.418
Authors: Sylvia M LaCourse; Barbra A Richardson; John Kinuthia; A J Warr; Elizabeth Maleche-Obimbo; Daniel Matemo; Lisa M Cranmer; Jaclyn N Escudero; Thomas R Hawn; Grace C John-Stewart Journal: BMJ Open Date: 2020-01-21 Impact factor: 2.692